Glibenclamide reduces secondary brain damage after experimental traumatic brain injury

Neuroscience

Volumn 272, Issue , 2014, Pages 199-206

  Zweckberger, K ^a   Hackenberg, K ^a   Jung, C S ^a   Hertle, D N ^a   Kiening, K L ^a   Unterberg, A W ^a   Sakowitz, O W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain edema; Cerebral metabolism; Epileptic seizures; Glibenclamide; Secondary brain damage; Traumatic brain injury

Indexed keywords

GLIBENCLAMIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN CONTUSION; BRAIN DAMAGE; BRAIN ELECTROPHYSIOLOGY; BRAIN METABOLISM; BRAIN WATER; CONTINUOUS INFUSION; CONTROLLED STUDY; EXPERIMENTAL DISEASE; EXPERIMENTAL TRAUMATIC BRAIN INJURY; GRAVIMETRY; HEART RATE; INCLINED BEAM WALKING TEST; INTRACRANIAL PRESSURE; LOADING DRUG DOSE; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MOTOR PERFORMANCE; NERVOUS SYSTEM FUNCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SECONDARY BRAIN DAMAGE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BRAIN EDEMA; BRAIN INJURIES; DISEASE MODEL; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; METABOLISM; NERVE CELL; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN EDEMA; BRAIN INJURIES; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; GLYBURIDE; INTRACRANIAL PRESSURE; MAGNETIC RESONANCE IMAGING; NEURONS; RATS, SPRAGUE-DAWLEY;

EID: 84901341149     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.040     Document Type: Article

References (36)

1. Alessandri B., Heimann A., Filippi R., Kopacz L., Kempski O. Moderate controlled cortical contusion in pigs: effects on multi-parametric neuromonitoring and clinical relevance. J Neurotrauma 2003, 20(12):1293-1305.
2. Berger S., Schürer L., Härtl R., Messmer K., Baethmann A. Reduction of post- traumatic intracranial hypertension by hypertonic /hyperoncotic saline/dextran and hypertonic mannitol. Neurosurgery 1995, 37(1):98-107.
3. Brain Trauma Foundation, (BTF), AANS Joint Section on Neurotrauma and Critical Care (2007) Guidelines for the management of severe head injury: 3rd Edition. J Neurotrauma (Suppl)24(1):1-106.
4. Buckingham S.C., Campbell S.L., Haas B.R., Montana V., Robel S., Ogunrinu T., Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011, 17(10):1269-1274.
5. Chamoun R., Suki D., Gopinath S.P., Goodman J.C., Robertson C. Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J Neurosurg 2010, 113(3):564-570.
6. Cremer C.M., Palomero-Gallagher N., Bidmon H.J., Schleicher A., Speckmann E.J., Zilles K. Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain. Neuroscience 2009, 163(1):490-499.
7. Deeley R.G., Westlake C., Cole S. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006, 86:849-899.
8. Finke ME (2012), Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline. Continuum (MinneapMinn). 2012, 18(3), pp. 640-654.
9. Goodman J.C., Valadka A.B., Gopinath S.P., Uzura M., Robertson C.S. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med 1999, 27(9):1965-1973.
10. Hillered L., Vespa P.M., Hovda D.A. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005, 22(1):3-41.
11. Hutchinson P.J., Al-Rawi P.G., O'Connell M.T., Gupta A.K., Maskell L.B., Hutchinson D.B., Pickard J.D., Kirkpatrick P.J. Monitoring of brain metabolism during aneurysm surgery using microdialysis and brain multiparameter sensors. Neurol Res 1991, 21(4):352-358.
12. Hutchinson P.J., Al-Rawi P.G., O'Connell M.T., Gupta A.K., Pickard J.D., Kirkpatrick P.J. Biochemical changes related to hypoxia during cerebral aneurysm surgery: combined microdialysis and tissue oxygen monitoring: case report. Neurosurgery 2000, 46(1):201-206.
13. Kang N., Xu J., Xu Q., Nedergaard M., Kang J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J Neurophysiol 2005, 94(6):4121-4230.
14. Kett-White R., Hutchinson P.J., Al-Rawi P.G., Gupta A.K., O'Connell M.T., Pickard J.D., Kirkpatrick P.J. Extracellular lactate/pyruvate and glutamate changes in patients during per-operative episodes of cerebral Ischaemia. Acta Neurochir Suppl 2002, 81:363-365.
15. Kunte H., Schmidt S., Eliasziw M., del Zoppo G.J., Simard J.M., Masuhr F., Weih M., Dirnagl U. Sulfonylureas improves outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke 2007, 38(9):2526-2530.
16. Marks J.A., Li S., Gong W., Sanati P., Eisenstadt R., Sims C., Smith D.H., Reilly P.M., Pascual J.L. Similar effects of hypertonic saline and mannitol on the inflammation of the blood-brain barrier microcirculation after brain injury in a mouse model. J Trauma Acute Care Surg 2012, 73(2):351-357.
17. Obrenovitch T.P. High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence?. Ann N Y Acad Sci 1999, 890:273-286.
18. Patel A.D., Gerzanich V., Geng Z., Simard J.M. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol 2010, 69(12):1177-1190.
19. Persson L., Valtysson J., Enblad P., Warme P.E., Cesarini K., Lewen A., Hillered L. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 1996, 84(4):606-616.
20. Popovich P.G., Lemeshow S., Gensel J.C., Tovar C.A. Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury. Exp Neurol 2012, 233(2):615-622.
21. Sakowitz O.W., Unterberg A.W., Stover J.F. Neuronal activity determined by quantitative EEG and cortical microdialysis is increased following controlled cortical impact injury in rats. Acta Neurochir Suppl 2002, 81:221-223.
22. Simard J.M., Chen M., Tarasov K.V., Bhatta S., Ivanova S., Melnitchenko L., Tsymbalyuk N., West G.A., Gerzanich V. Newly expressed SUR-1 regulated NC Ca-ATP channel mediates cerebral edema after ischemic stroke. Nat Med 2006, 12(4):433-440.
23. Simard J.M., Tsymalyuk O., Ivanov A., Ivanova S., Bhatta S., Geng Z., Woo S.K., Gerzanich V. Endothelial sulfonylurea receptor 1 regulates NCCa-ATP channels mediated progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest 2007, 117(8):2105-2113.
24. Simard J.M., Tarasov K.V., Gerzanich V. Non-selective cation channels, transient receptor potential channels and ischemic stroke. Biochim Biophys Acta 2007, 1772:947-957.
25. Simard J.M., Yurovsky V., Tsymbalyuk N., Melnichenko L., Ivanova S., Gerzanich V. Protective effects of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 2009, 40(2):604-609.
26. Simard J.M., Geng Z., Woo S.K., Ivanova S., Tosun C., Melnichenko L., Gerzanich V. Glibenclamide reduces inflammation, vasogeneticedema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009, 29(2):317-330.
27. Simard J.M., Kibourne M., Tsymalyuk O., Tosun C., Caridi J., Ivanova S., Keledjian K., Bochicchio G., Gerzanich V. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma 2009, 26(12):2257-2267.
28. Simard J.M., Woo S.W., Schwartzbauer G.T., Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab 2012, 32(9):1699-1717.
29. Simard J.M., Tsymalyuk O., Keledjian K., Ivanov A., Ivanova S., Gerzanich V. Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol 2012, 233(1):566-574.
30. Simard J.M., Popovich P.G., Tsymalyuk O., Gerzanich V. Spinal cord injury with unilateral versus bilateral primary hemorrhage - effects of glibenclamide. Exp Neurol 2012, 233(2):829-835.
31. Vàzquez-Lòpez A., Sierra-Paredes G., Sierra-Maruno G. Seizures induced by microperfusion of glutamate and glycine in the hippocampus of rats pretreated with latrunculin A. Neurosci Lett 2005, 388(2):81-85.
32. Walcott B.P., Kahle K.T., Simard J.M. Novel treatment targets for cerebral edema. Neurotherapeutics 2012, 9(1):65-72.
33. Woo S.K., Kwon M.S., Ivanov A., Gerzanich V., Simard J.M. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem 2013, 288(5):3655-3667.
34. Zhou Y., Fathali N., Lekic T., Tang J., Zhang J.H. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats. Brain Res 2009, 1270:131-139.
35. ZweckbergerK Stoffel M., Baethmann A., Plesnila N. Effect of decompression craniotomy on increase of contusion volume and functional outcome after controlled cortical impact in mice. J Neurotrauma 2003, 20(12):1307-1314.
36. Zweckberger K., Erös C., Zimmermann R., Kim S.W., Engel D., Plesnila N. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J Neurotrauma 2006, 23(7):1083-1093.